Turning Pennies into dollars: Lifespan Inc. (Pink Sheets:LSPN)

Turning Pennies into dollars: Lifespan Inc. (Pink Sheets:LSPN)

Are you a public company looking for exposure?

Contact RealPennies.com - 212-662-2147



For more info: http://www.realpennies.com/otc/lspn

Monday March 30, 2009

Lifespan Inc. (Pink Sheets:LSPN) (www.lifespaninc.com) Lifespan announces that when Baby Boomers start turning 65 in 2011, approximately 8,000 Americans will become Medicare eligible every single day. The US currently has 37 million people over age 65, a figure the Census Bureau projects will hit 67 million by 2020 and 71.5 million by 2030 – nearly 20 percent of the U.S. population. At the same time, medical technology advances will continue to improve the survival rate of severely ill and injured patients, who then need home based health care, extensive therapy and nursing care.

Dr. Quyami the Company’s Chief Scientist and the Director of the nonprofit Centre of Excellence for Surgical Education & Innovation (www.cesei.org) stated that, “Technically advanced telemedicine based home healthcare is an extremely cost-effective, yet significantly underutilized health care option for seniors on Medicare.”

Additionally Dr. Quyami said, “In these times, it is crucially important that every taxpayer dollar is efficiently utilized. For basic health care, that means helping more Medicare patients receive the benefits of technically advanced home care systems, and online information and provider intervention, while expanding technical capacity to more economically accommodate their needs.”

Dr. William Blase is also adding his considerable expertise to the Lifespan Project by joining the Medical Advisory Board. Dr. Blase has had a distinguished career in all aspects of the medical profession, with a practice emphasis on Ophthalmology, a background in medical research, as well as administration and management issues of modern medical practice.

Dr. Blase is formerly the Chairman of the Department of Ophthalmology at the Hemet Valley Hospital and a Director of California Eye Care. Dr. Blase was also a Trustee for a California District Hospital System. Dr. Blase has also served eight years as a Trustee of the Valley Health System in Riverside California and was formerly the Chairman of the Board, as well as a Trustee of the Employee Health, Pension, and Retirement Funds.

Dr. Blase is also a Diplomate of the National Board of Medical Examiners, the American Board of Ophthalmology, and has published numerous articles and several book chapters. Dr. Blase is a graduate of Dartmouth College, the University of Virginia School of Medicine and Oxford University, and did his medical post graduate training at Johns Hopkins in Baltimore MD.



Realpennies.com



Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on http://www.realpennies.com/start.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. This may contain forward-looking statements and are not guarantees of performance. Reproduction of this without written permission is prohibited.

RealPennies.com

Phone: 212-662-2147

info [at] realpennies.com

 

 

(OTCBB:AEMD) Aethlon Medical, Inc

Turning Pennies into dollars: (OTCBB:AEMD) Aethlon Medical, Inc

Are you a public company looking for exposure?

Contact RealPennies.com - 212-662-2147



For more info: http://www.realpennies.com/otc/aemd

Aethlon Medical Announces Completion of 30-Day Hepatitis-C Treatment Study

(OTCBB:AEMD) Aethlon Medical, Inc.

Aethlon Medical Announces Completion of 30-Day Hepatitis-C Treatment Study

Wednesday February 18, 10:42 am ET

SAN DIEGO-Aethlon Medical, Inc. announced recently that it has completed a 30-day treatment case study to further evaluate the safety and efficacy of the Aethlon Hemopurifier® as a candidate treatment for Hepatitis-C Virus infection. The Hemopurifier® is a first-in-class medical device that assists the immune response in combating infectious disease through real-time therapeutic filtration of infectious viruses and immunosuppressive proteins. As in previous studies, which demonstrated robust viral load reductions resulting from three Hemopurifier® treatments administered in a one-week trial, the study enrolled an HCV patient suffering from end-stage renal disease requiring regular kidney dialysis treatment. The study goal was to further demonstrate the Aethlon Hemopurifier® inhibits the progression of HCV in infected ESRD patients. The study protocol provided for 12 Hemopurifier treatments to be administered during the patient?s normally scheduled dialysis treatment. As a result, a 4-hour Hemopurifier® treatment was administered thrice weekly over a period of 30 days. There were no observed adverse events were reported in any of the treatments. The study was conducted at the Fortis Hospital in Delhi, India. Aethlon will disclose viral load and associated data upon receipt from testing laboratories. The insight obtained from the study will help define future clinical protocols and early commercialization strategies. The study data may also be utilized to expand the scope of an IDE submission to the FDA to include the potential use of the Hemopurifier® in the United States as a device designed for the single-use removal of HCV from blood. At present, the focus of Aethlon?s IDE submission has been directed towards high risk bioterror and emerging pandemic threats.

It is estimated that up to 20% of the 1.6 million global ESRD population is infected with HCV. Beyond the treatment of infected ESRD patients, the overall opportunity for the Hemopurifier® is HCV care is significant, as approximately 180 million people worldwide (3% of the world's population) are HCV infected. According to the World Health Organization , only 30-50% of infected patients will beneficially respond to the 48-week pegylated interferon-ribavirin treatment standard.

?While we still have much work ahead, I am proud that our research and clinical programs allow us the opportunity to expand the therapeutic filtration industry beyond kidney dialysis and into the much larger infectious disease and cancer markets,? stated Aethlon Chairman and CEO, Jim Joyce. ?The continued demonstration of Hemopurifier® safety and effectiveness increases the likelihood that our technology will be available to extend and improve the lives of those suffering from these horrific conditions,? concluded Joyce.

In a previous studies conducted the Fortis Hospital, six ESRD patients received a series of three, 4-hour Hemopurifier® treatments every other day during the course of one week. The treatment regimen also mirrored the patient's normal kidney dialysis schedule, allowing for the inclusion of the Hemopurifier® without disrupting dialysis treatment. Robust viral load reductions were observed in three HCV patients who completed the three-treatment protocol. Patient #1 had a 95% reduction three days post treatment and 89% reduction seven days post treatment. Patient #2 had a 85% reduction three days post treatment and 50% reduction seven days post treatment, and patient #3 had a 60% reduction three days post treatment and 83% reduction seven days post treatment.

Aethlon additionally disclosed that it soon expects the receipt of viral load and blood chemistry data resulting from a recently completed 30-day HIV treatment case study. The Hemopurifier® is the first medical device to target the treatment of both HIV and HCV, as well as a broad-spectrum of other infectious viral pathogens.

About Aethlon Medical

Aethlon Medical creates diagnostic and therapeutic filtration devices to improve the health of individuals afflicted with infectious disease and cancer. The Company?s lead product, the Aethlon Hemopurifier®, is a first-in-class artificial adjunct to the immune system proven to capture infectious viruses and immunosuppressive particles from circulation. The device targets to inhibit disease progression of Hepatitis-C Virus and Human Immunodeficiency Virus , and serves as a broad-spectrum treatment countermeasure against bioterror and emerging pandemic threats. The Hemopurifier® also holds promise in cancer care, as research studies verify the Hemopurifier® effectively captures immunosuppressive exosomes that are secreted by tumors to kill-off immune cells. At present, over sixty-five Hemopurifier® treatments have been conducted in multi-site studies at the Apollo Hospital, Fortis Hospital, and Sigma New-Life Hospital in India. The studies enrolled end-stage renal disease patients infected with either HCV or HIV. In addition to establishing treatment safety, robust viral load reductions have been reported in HCV-infected patients who completed a three-treatment protocol during the course of one week.

Research studies have also demonstrated the Hemopurifier® is effective in capturing a broad-spectrum of viruses untreatable with drug therapy, including several of world?s deadliest bioterror and pandemic threats. These include: Dengue hemorrhagic fever , Ebola hemorrhagic fever , Lassa hemorrhagic fever , H5N1 avian influenza , the reconstructed 1918 influenza virus , West Nile virus , and Vaccinia and Monkeypox , which both serve as models for human smallpox infection. The studies were conducted with the assistance of researchers representing: The U.S. Army Medical Research Institute of Infectious Diseases ; The Centers for Disease Control and Prevention ; The National Institute of Virology ; The Battelle Biomedical Research Center ; and The Southwest Foundation for Biomedical Research .

In additional to therapeutic market opportunities, Aethlon is leveraging principles underlying the Hemopurifier® technology platform to establish a pipeline of clinical and research diagnostic products and services. Additional information regarding Aethlon Medical can be accessed online at www.aethlonmedical.com.

Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the Company?s ability to raise capital when needed, the Company?s ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company?s ability to manufacture its products and provide its services, the impact of government regulations, patent protection on the Company?s proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company?s Securities and Exchange Commission filings.

Contact:

Aethlon Medical, Inc. Prashant Mehta, Ph.D. Director of Business Development 858.459.7800 x303 pmehta@aethlonmedical.com or Jim Frakes Senior VP Finance 858.459.7800 x300 jfrakes@aethlonmedical.com or Jim Joyce Chairman, CEO 858.459.7800 x301 jj@aethlonmedical.com Source: Aethlon Medical, Inc.

Profile for Aethlon Medical, Inc.

Aethlon Medical, Inc. engages in the research and development of a medical device known as the Hemopurifier that removes harmful substances from the blood. The company’s Hemopurifier platform technology is designed to reduce the presence of infectious viruses and other toxins from human blood. It focuses on developing therapeutic devices to treat acute viral conditions caused by pathogens targeted as potential biological warfare agents, and chronic viral conditions, including HIV/AIDS and Hepatitis-C. The company was founded in 1991 and is headquartered in San Diego, California. Detailed AEMD Company Description...

LAST $0.18 USD

Find out more about AEMD



Realpennies.com



Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on http://www.realpennies.com/start.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. This may contain forward-looking statements and are not guarantees of performance. Reproduction of this without written permission is prohibited.

RealPennies.com

Phone: 212-662-2147

info [at] realpennies.com

 

 

(OTCBB:QMCI) QuoteMedia, Inc.

Turning Pennies into dollars: (OTCBB:QMCI) QuoteMedia, Inc.

Are you a public company looking for exposure?

Contact RealPennies.com - 212-662-2147



For more info: http://www.realpennies.com/otc/qmci

John Frey Joins QuoteMedia, Formerly of Thomson Financial, ILX Systems and Southwest Securities

(OTCBB:QMCI) QuoteMedia, Inc.

John Frey Joins QuoteMedia, Formerly of Thomson Financial, ILX Systems and Southwest Securities

Wednesday February 18, 4:00 pm ET

PHOENIX-QuoteMedia, Inc. , a leading provider of market data, corporate research information and financial applications, announced recently the appointment of Mr. John G. Frey as Director of Corporate Sales.

Mr. Frey brings to QuoteMedia over 20 years of experience in providing innovative solutions to the financial services industry, beginning as one of the original sales people in the early days of ILX Systems where he played a significant role in its growth. Later, Mr. Frey served as Regional Vice President for Thomson Financial where he was responsible for several of Thomson?s largest accounts. Mr. Frey has also held management positions with other industry leaders, including Southwest Securities, where he was National Sales Manager of RIA Clearing and most recently as Regional Vice President of Beacon Capital Markets, Inc. where he was directly responsible for the sale of an electronic fixed income trading platform.

Additionally, Mr. Frey has held senior positions focusing on virtually every aspect of servicing and providing solutions to clients within the financial services industry. Having held his FINRA Series 7, 24, 63 and also a Series 65 license his experience spans operations, marketing, sales management, electronic trading and compliance.

?John is very well-known in the market data industry, and we?re very pleased that he is joining QuoteMedia,? said Dave Shworan, C.E.O. of QuoteMedia, Ltd. ?His wealth of experience and unparalleled knowledge in all aspects of our industry make him an ideal addition to our company. The entire QuoteMedia team is looking forward to working with John to expand our business and provide first-class solutions to our clients.?

?QuoteMedia?s emergence as a major player in the financial data industry over the past few years has really impressed me,? said Mr. Frey. ?The remarkable client list that QuoteMedia has already achieved speaks volumes about the kind of acceptance the company is generating for its data solutions, and the potential for further growth is extraordinary. I?m very happy to be joining QuoteMedia. It?s definitely a company on the move, and I?m very excited to be a part of it.?

About QuoteMedia, Inc.

QuoteMedia is a leading software developer and syndicator of financial market information and streaming financial data solutions to media, corporations, online brokerages and financial services companies. The Company licenses interactive stock research tools such as streaming real-time quotes, market research, news, charting, option chains, SEC filings, corporate financials, insider reports, market indices, portfolio management systems, and data feeds. QuoteMedia provides data and services for companies such as the NASDAQ, the OTCBB, Dow Jones & Company, Sungard, Wells Fargo, Penson Worldwide, Motorola, General Electric, Forbes.com, Scotia Capital, Southwest Securities, AIM Trimark, Zecco Trading, Zacks Investment Research, , Regal Securities, Broadridge Financial Systems, ChoiceTrade, Qtrade Financial Group, CNW Group, TradeFreedom, Questrade, Schaeffer's Investment Research and others. For more information, please visit: www.quotemedia.com.

Contact:

Profile for QuoteMedia, Inc.

QuoteMedia, Inc. develops and distributes financial market data and related services. It specializes in the collection, aggregation, and delivery of delayed and real-time financial data content through Internet. The company offers various market information and services, including streaming stock market data feeds, research and analysis information, content applications, portfolio management systems, software products, corporate investor relations provisioning, news services, wireless applications, and custom development. It offers data feed services covering equities, options, futures, commodities, currencies, mutual funds, and indices; and interactive content and data applications, includi... Detailed QMCI Company Description...

LAST $0.07 USD

Find out more about QMCI



Realpennies.com



Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on http://www.realpennies.com/start.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. This may contain forward-looking statements and are not guarantees of performance. Reproduction of this without written permission is prohibited.

RealPennies.com

Phone: 212-662-2147

info [at] realpennies.com

 

 

(OTCBB:TDCP) 3DIcon Corp.

Turning Pennies into dollars: (OTCBB:TDCP) 3DIcon Corp.

Are you a public company looking for exposure?

Contact RealPennies.com - 212-662-2147



For more info: http://www.realpennies.com/otc/tdcp

3DIcon Files Utility Patent for Breakthrough 3D CSpace® Technology

(OTCBB:TDCP) 3DIcon Corp.

3DIcon Files Utility Patent for Breakthrough 3D CSpace® Technology

Wednesday February 18, 6:00 am ET

Application Coincides with 3DIcon?s Launch of Aggressive Program to Market Its Historic Creation

TULSA, Okla.-3DIcon Corporation announced recently that it has filed a utility patent application with the U.S. Patent and Trademark Office for its breakthrough 3D imaging technology, CSpace®. This filing converts the provisional patent application filed for CSpace in 2008.

3DIcon recently announced an historic breakthrough in the development of 3D display technologies with the invention of a working prototype of its proprietary 3D display system CSpace, which is capable of rendering high-resolution, 360-degree, three-dimensional images without any viewing aids. CSpace is the first system of its kind that has no mechanical moving parts and is also scalable.

?The economy? No frowns around here. We?re right on target,? said Martin Keating, 3DIcon?s chairman and CEO. ?This filing marks a key milestone in the commercialization of our premier and historic 3D creation. We?ve just begun our major international outreach program to potential users of the first genuine three-dimensional display technology ever. It?s an exciting time, with an incredible future. For all of us.?

The utility patent for the CSpace technology, invented by Dr. Hakki H. Refai and Dr. James J. Sluss, Jr. is titled ?Virtual Moving Screen for Rendering Three Dimensional Image.? This technology offers substantial potential benefits to the 3D imaging industry. 3DIcon?s patent describes a virtual moving screen which is compatible with virtually all 3D graphic engines. The virtual moving screen can receive input from the rendering engine and render images on displays that require no moving parts which enhance the size, color, clarity, and portability of 3D images.

About 3DIcon Corporation

3DIcon Corporation is a developer of groundbreaking 3D projection and display technologies that are being designed to produce full color, 360° volumetric images. The Company recently completed a working prototype of its flagship technology, CSpace®, a breakthrough in 3D imaging, along with concluding a key licensing deal for the CSpace technology. 3DIcon has also launched its first software product, Pixel Precision®, which targets the R&D market for developers using Texas Instruments' DLP® line of products.

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION ACT OF 1995

With the exception of historical information, the matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of 3DIcon could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the company's operations, inability to hire and retain qualified personnel, and changes in the general economic climate. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by 3DIcon, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements.

Contact:

3DIcon Corporation Investor and Media Relations Dilek Mir, 310-591-5619 Source: 3DIcon Corporation

Profile for 3DIcon Corp.

3DIcon Corporation focuses on developing and marketing full-color, 360-degree person-to-person holographic technology. It intends to serve various industries, such as retail, manufacturing, entertainment, medical, healthcare, transportation, homeland security, and the military. The company, formerly known as First Keating Corporation, was incorporated in 1995 and is based in Tulsa, Oklahoma. Detailed TDCP Company Description...

LAST $0.04 USD

Find out more about TDCP



Realpennies.com



Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on http://www.realpennies.com/start.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. This may contain forward-looking statements and are not guarantees of performance. Reproduction of this without written permission is prohibited.

RealPennies.com

Phone: 212-662-2147

info [at] realpennies.com

 

 

(OTCBB:MGUY) Mogul Energy International, Inc.

Turning Pennies into dollars: (OTCBB:MGUY) Mogul Energy International, Inc.

Are you a public company looking for exposure?

Contact RealPennies.com - 212-662-2147



For more info: http://www.realpennies.com/otc/mguy

Mogul Energy Announces Agreement to Acquire a 40% Interest in Excelaron LLC

(OTCBB:MGUY) Mogul Energy International, Inc.

Mogul Energy Announces Agreement to Acquire a 40% Interest in Excelaron LLC

Wednesday February 18, 3:59 pm ET

SEATTLE, WA-Feb 18, 2009 - Mogul Energy International, Inc. announced recently that it has entered into an agreement with Excelaron LLC wherein Mogul Energy has acquired a 40% membership interest in Excelaron LLC, a California-based company. Excelaron LLC is in the process of developing oil and gas leases that Excelaron has entered into that are located in the state of California. Naeem Tyab, President of Mogul Energy, stated, "I believe that the agreement for Mogul Energy to acquire a 40% interest in Excelaron and to work with Excelaron to develop an oil and gas project in California presents a tremendous opportunity for the Company." Greater detail as to the agreement and other activities of the Company may be found in the Company EDGAR filings at www.sec.gov.

Information concerning Mogul Energy International:

Mogul Energy is an oil and gas exploration company with headquarters in Seattle, Washington.

Mogul Energy is a Delaware corporation with its principal place of business in Seattle, Washington. The common shares of Mogul Energy are quoted on the OTC Bulletin Board system under the symbol 'MGUY,' and the Frankfurt Stock Exchange under the symbol 'BKX.' Further information concerning Mogul Energy can be found in the Company's filings with the U.S. Securities and Exchange Commission .

Forward-Looking Statements

This news release contains "forward-looking statements" within the meaning of the securities laws, which are based on current expectations and beliefs, as well as on a number of assumptions concerning future events made with information that is currently available. Statements in this news release that are not historical facts are forward-looking statements that are subject to risks and uncertainties. Words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management, including, but not limited to, the Company's ability to negotiate, enter into, perform and consummate the business combination described in this release. Inherent in the Company's business plan is a belief that Mogul Energy can successfully explore oil and gas properties in Egypt and Canada, and that the Company can participate in the development of those properties. Readers are cautioned not to put undue reliance on such forward-looking statements, which are not a guarantee of performance and are subject to a number of uncertainties and other factors, many of which are outside of Mogul Energy's control, which could cause actual results to differ materially from such statements. For a more detailed description of the factors that could cause such a difference, please refer to Mogul Energy's filings with the U.S. Securities and Exchange Commission. Mogul Energy International, Inc. assumes no obligation to update or supplement such forward-looking statements other than as required by law.

Contact:

Contact Information: Company Contact: Naeem Tyab Mogul Energy Tel: 206-357-4220 naeem@mogulenergy.com http://www.mogulenergy.com   Source: Mogul Energy International Inc.

Profile for Mogul Energy International, Inc.

Mogul Energy International, Inc. operates as an independent oil and gas exploration company. It also involves in financing and acquiring drilling prospects. The company holds a 100% interest in approximately 9,300 acres situated in south east Saskatchewan, Canada; and a 20% working interest in the East Wadi Araba Concession located in the Gulf of Suez, covering approximately 295 square kilometers in the sovereign territory of the Arab Republic of Egypt. Mogul Energy International was founded in 2005 and is based in Seattle, Washington. Detailed MGUY Company Description...

LAST $0.02 USD

Find out more about MGUY



Realpennies.com



Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on http://www.realpennies.com/start.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. This may contain forward-looking statements and are not guarantees of performance. Reproduction of this without written permission is prohibited.

RealPennies.com

Phone: 212-662-2147

info [at] realpennies.com

 

 

(OTCBB:ALYI) Alternet Systems, Inc.

Turning Pennies into dollars: (OTCBB:ALYI) Alternet Systems, Inc.

Are you a public company looking for exposure?

Contact RealPennies.com - 212-662-2147



For more info: http://www.realpennies.com/otc/alyi

Alternet Systems, Inc. to Present at 5th Annual Winter Technology Conference Hosted by Security Research Associates, Inc.

(OTCBB:ALYI) Alternet Systems, Inc.

Alternet Systems, Inc. to Present at 5th Annual Winter Technology Conference Hosted by Security Research Associates, Inc.

Wednesday February 18, 9:00 am ET

MIAMI, FL-Feb 18, 2009 - Alternet Systems, Inc. , a leading provider of E-Commerce and Mobile transaction services for the transportation and utility markets, recently announced Henryk Dabrowski, Chief Executive Officer will be presenting at the 5th Annual Winter Technology Conference hosted by Security Research Associates, Inc. The conference will be held on Monday, March 9th at the Omni Hotel in San Francisco.

Conference attendees will include a select group of institutional portfolio managers and analysts, and will feature CEOs and CFOs from some of the fastest growing companies in the technology sector. SRA has arranged for webcasting of company presentations during this event. To access the lobby page for the webcast of presenting companies please go to: http://www.wsw.com/webcast/sra8/

"Alternet is very excited about presenting at SRA's Annual Winter Technology Conference. We have spent the last year solidifying some key partnerships to expand our service offerings. With those partnerships firmly in place, we look forward to continued expansion in rapid growth markets as well as the continued development and expansion of our product and service offerings in both the transportation and utility markets."

About Alternet Systems

Alternet Systems, Inc. provides: telecommunications services; education and health-care application software and systems; and electronic transaction platforms for the mass transportation and utility markets. Alternet Systems, Inc. is a U.S. corporation headquartered in Miami, Florida.

About Security Research Associates, Inc.

Security Research Associates, Inc. was founded in San Francisco in 1980 and, recently, offers investment banking and M&A services as well as institutional brokerage services. A boutique firm by design, SRA works with a select group of portfolio managers from around the country and focuses on technology and life science companies in the micro and small cap arenas. For more information about SRA see our web site at www.sracap.com or call us at 415-925-0346.

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.

Contact:

For More Information:   Red River Advisors alternet@redriveradvisors.com 214-556-5927   Source: Alternet Systems, Inc.

Profile for Alternet Systems, Inc.

Alternet Systems, Inc. provides telecom, application software, and transactions solutions for government, business, schools, hospitals, and residents. It offers convergent voice and data services over IP networks; education and health-care application software and systems; and electronic transaction platforms for the mass transportation and utility markets primarily located in Latin America, North America, and the Caribbean. In addition, the company develops, markets, and sells Internet application systems and software under the names ‘SchoolWeb’ and ‘HealthWeb’. Alternet Systems, Inc. was founded in 2002 and is based in Vancouver, Canada. Detailed ALYI Company Description...

LAST $0.18 USD

Find out more about ALYI



Realpennies.com



Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on http://www.realpennies.com/start.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. This may contain forward-looking statements and are not guarantees of performance. Reproduction of this without written permission is prohibited.

RealPennies.com

Phone: 212-662-2147

info [at] realpennies.com

 

 

(OTC:PRRY) Planet Resource Recovery, Inc.

Turning Pennies into dollars: (OTC:PRRY) Planet Resource Recovery, Inc.

Are you a public company looking for exposure?

Contact RealPennies.com - 212-662-2147



For more info: http://www.realpennies.com/otc/prry

Planet Resource Recovery, Inc.'s PetroLuxus(TM) Featured in The American Oil & Gas Reporter Magazine as Solution Option in Chemical EOR

(OTC:PRRY) Planet Resource Recovery, Inc.

Planet Resource Recovery, Inc.'s PetroLuxus Featured in The American Oil & Gas Reporter Magazine as Solution Option in Chemical EOR

Thursday February 19, 8:00 am ET

HOUSTON, TX-Feb 19, 2009 - Planet Resource Recovery, Inc. , developer, manufacturer and marketer of the PetroLuxus family of green technology products, recently announced that a feature article has been published in the February 2009 edition of The American Oil & Gas Reporter monthly magazine, titled "SILICA SOLUTION OPTION IN CHEMICAL EOR."

Based on field results from PetroLuxus products treatments in the EOR market, Planet was asked to submit a three page article detailing the effectiveness and methodology of why PetroLuxus works to recover trapped oil. The article discusses the scope of marginal wells in the U.S., current methods employed to coax oil to the surface, why PetroLuxus is a new, cost-effective solution, a summary of field results exemplifying production increases and other uses at the well site for environmental remediation and maintenance. View article at http://www.planetresource.net/PDF/PlanetResourceRecovery0209.pdf.

Established in 1958, The American Oil & Gas Reporter serves the exploration, drilling and production segments of the oil and gas industry. These include independent, diversified and major integrated oil and gas producers and operators; geophysical, drilling and well servicing contractors: service, supply and manufacturing companies; landman, consulting and engineering firms; as well as others allied to the field. The magazine is the Official Publication of twenty-nine Associations of Oil & Gas Producers and One Oil & Gas Industry Trade Show. For more information visit www.aogr.com

About Planet Resource Recovery, Inc.

Planet Resource Recovery, Inc. is the developer, manufacturer and marketer of the PetroLuxus family of green technology products, a proprietary environmentally friendly chemical compound that dislodges oil in practically all natural and man-made environments. The PetroLuxus family of products are effective and efficient solutions for the remediation and recovery of petroleum-based products. PetroLuxus applications include Enhanced Oil Recovery, Oil Sands, oil spills, oil tank farm cleaning, marine ship cleaning, remediation of oil sludge pits, treatment of raw fuel feedstocks, waste oil segregation and biodiesel, to name a few. Through the acquisition and formation of wholly owned subsidiaries, Planet Resource Recovery, Inc. deploys the PetroLuxus products. Oil Recovery Ventures, Inc. deploys PetroLuxus through joint ventures in the Enhanced Oil Recovery market.

For an audio/visual demonstration of PetroLuxus, click on the link http://www.planetresource.net/index-21.html

For more information visit: http://www.planetresource.net or http://www.petroluxus.com

Safe Harbor Statement

Certain statements in this release are "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the Company's ability to meet the terms and conditions required to obtain its project financing, risks and delays associated with product development, risk of market acceptance of new products, risk of technology or product obsolescence, competitive risks, reliance on development partners and the need for additional capital.

Contact:

Company Contact: Enrique M. Salinas III Planet Resource Recovery, Inc. 281-996-5315 Email Contact   Media Contact: Rod Mitchell 281-350-5506 Email Contact   Source: Planet Resource Recovery, Inc.

Profile for Planet Resource Recovery, Inc.

Planet Resource Recovery, Inc., a petrochemical/oil services company, develops a proprietary chemical that dislodges hydrocarbons in natural and man-made environments. The company’s flagship product, PetroLuxus, and its derivative product lines have qualities to break hydrocarbon chains on a molecular level for cost-effective remediation and recovery of petroleum and petroleum-based materials. Its prospective markets for remediation and recovery include oil tank farm cleaning, marine ship cleaning, oil sludge pits, contaminated soil/oil spills, bio-diesel, waste oil segregation, heavy oil, tar sands, and enhanced oil recovery. The company was founded in 2005 and is based in Houston, Texas. Detailed PRRY Company Description...

Find out more about PRRY



Realpennies.com



Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on http://www.realpennies.com/start.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. This may contain forward-looking statements and are not guarantees of performance. Reproduction of this without written permission is prohibited.

RealPennies.com

Phone: 212-662-2147

info [at] realpennies.com